Weekly Rundown: Small-Cap Stocks with Key Catalysts (September 2-5)

We’ve tracked the latest disclosures and corporate developments to highlight this week’s most impactful small-cap catalysts. Below is our weekly preview for September 2-5.

--

Companies participating in the Cantor Fitzgerald Global Healthcare Conference 2025 (September 3–5):

ORGO, JSPR, GOSS, CMPX, ESPR, CMPS, IMAB, HCAT, ACRS, DCGO, CASI, ALMS, CERS, IVVD, CABA, CNTB, ARTV, CNTX, ALXO, CATX, ELUT, ALEC, IFRX, AQST, ELDN, CLYM, SKYE, CUE, ATAI, TLSI, EQ, CRIS, CTMX, TARA, NUVB, EPRX, ABOS, ANNX, SLDB, RCKT, PYXS, RCEL, LUCD / PAVM

Companies participating in the Citi 2025 BioPharma Back to School Conference (Wednesday, September 3, 2025 • Boston, MA):

DRTS, EPRX, PRME, CMPX, OLMA, VOR, VYGR, ABOS, SANA, RXRX, NUVB, PROK, CADL, BIOA, ALLO, SLDB

Companies presenting at the 2025 Annual Gateway Conference - One of the nation's premier investor events connecting high-growth companies with institutional investors, analysts, and capital markets professionals. The conference will take place September 4–5, 2025, at the Four Seasons Hotel in San Francisco, CA.:

HYLN, BW, VNTG, GAIA, GCTS, WYY, MOB, SNAL, SNYR, AMZE, JTAI, ISPO, DEFT, FUFU, BTM, KLTR, ATLN, LTRX, NRDY, UCL, TYGO, FTHM, ZSPC, AIRG, ZEO, AWRE, HTCR, WKHS, MSS, PMNT, FTRK, SOWG, SOBR, LCFY

Companies participating in the Wells Fargo Healthcare Conference (September 3–5, 2025):

CYH, ABSI, ENGN, VYGR, KYTX, FATE, MNKD, ABCL, ANNX, EDIT, MIST, SVRA, FHTX, ZNTL, QTTB, AKBA, TALK, LUNG, VTYX, KZR, CRDF, ALT, SGMO, RLAY, CTKB, IOVA, SANA, GERN

Other Companies with Catalysts This Week (September 2–7, 2025):

● DTIL → iECURE, Inc. will present new data from the ongoing OTC-HOPE trial (ECUR-506 for neonatal onset OTC deficiency) at:

• 6th International Symposium on UCDs (Sept 1–2, Kyoto, Japan)

• 15th International Congress of Inborn Errors of Metabolism (ICIEM, Sept 3–6, Kyoto, Japan)

● OLPX → Presenting at Barclays 18th Annual Global Consumer Staples Conference (Sept 2, Boston, MA). CEO Amanda Baldwin & COO/CFO Catherine Dunleavy speaking at 3:45 p.m. ET.

● KULR → Hosting booth at Commercial UAV Expo 2025 (Sept 2–4, Las Vegas, NV), showcasing KULR ONE® Air advanced lithium-ion system for UAV/UAM applications.

● PGEN → H.C. Wainwright Virtual Fireside Chat (Sept 2, 11 a.m.–12 p.m. ET). Participants: CEO Helen Sabzevari, PhD, and CCO Phil Tennant.

● EDIT → Hosting a webinar (Sept 2, 8:00 a.m. ET) to announce selection of its lead in vivo development candidate.

● LUMN → Participating in:

• Citi 2025 Global TMT Conference (Sept 3)

• BofA Media, Communications & Entertainment Conference (Sept 4)

● TEAD → Citi 2025 Global TMT Conference (Sept 3, New York, NY). Fireside chat scheduled 2:10–2:45 p.m. ET.

● BRLT → Goldman Sachs 32nd Annual Global Retailing Conference (Sept 3, New York, NY). Hosting investor meetings throughout the day.

● IRD → Ophthalmology Futures Forum (Paris, Sept 3):

• Panel: Gene & Cell Therapies for Retinal Diseases (12:20 p.m.)

• Opus Genetics Corporate Presentation (5:00 p.m.)

● CLSD → SCS delivery platform & CLS-AX program featured at EURETINA Congress (Sept 4–7, Paris). Also panel participation at Ophthalmology Futures Retina Forum (Sept 3).

● ENSC → Hosting symposium “Pain Management, RE-Invented: A New Era for Analgesia” at PAINWeek 2025 (Sept 3, Las Vegas, NV).

● HOVR →

• Gabelli Aerospace & Defense Symposium (Sept 4, NYC, Harvard Club)

• Deutsche Bank Aviation Forum (Sept 4, NYC, Deutsche Bank Center)

● BAER → Presenting at Gabelli Aerospace & Defense Symposium (Sept 4).

● BSGM → Needham Virtual Crypto 1x1 Conference (Sept 4). Hosting 1x1 investor meetings.

● TBLA → Participating in:

• Citi Global TMT Conference (Sept 3, Fireside Chat at 3:30 p.m. ET)

• Benchmark Annual TMT Conference (Sept 4)

● ATUS → CEO Dennis Mathew presenting at BofA Media, Communications & Entertainment Conference (Sept 4, 8:50 a.m. ET).

● BEAT → MDB Investor Summit 2025 (Sept 4, Dallas, TX). Live demos of FDA-cleared HeartBeam System.

• HRX Live 2025 (Sept 4–6, Atlanta, GA) – new AI ECG data presentation during AbstractX Happy Hour (Sept 4, 5:30 p.m. ET).

● RBBN → Presenting at TD Securities Tech Growth Cap Summit (Sept 4, New York, NY).

● SKYE → Hosting Virtual KOL Event on Phase 2a CBeyond™ trial topline results (Sept 4, 8:00 a.m. ET).

● ENTX → Presentations at ASBMR 2025 Annual Meeting (Seattle, WA):

• Oral Presentation (Sept 5, 11:45 a.m.) – Phase 2 EB613 bone density data

• Poster Presentation (Sept 7, 2:00–3:30 p.m.) – Next-gen EB613 with N-Tab™ technology

● HLLY → LS Fest East (Sept 5–7, Beech Bend Raceway Park).

● STXS → Technology showcased at HRX 2025 Digital Health Conference (Sept 4–6, Atlanta, GA).

● RFL → Cyclo Therapeutics presenting data on Trappsol® Cyclo™ at ICIEM 2025 (Sept 2–6, Kyoto, Japan).

● SGMO → Additional clinical data presentation at ICIEM 2025 (Sept 2–6, Kyoto, Japan).

● RZLV → CEO Daniel M. Wagner fireside chat at Citi Global TMT Conference (Sept 3, 4:10 p.m. ET, NYC).

● BGS → Fireside chat at Barclays Global Consumer Staples Conference (Sept 3, Boston, MA, 3:00 p.m. ET).

● GUTS → Completed enrollment in REMAIN-1 trial; 3-month data expected September 2025.

● SHFS → CEO Terry Mendez speaking at PBC Conference 2025 (Sept 3–4, Washington, D.C.).

● ALIT → CFO Jeremy Heaton presenting at Citi Global TMT Conference (Sept 4, NYC).

● UP → CEO George Mattson presenting at Jefferies Industrials Conference (Sept 4, NYC, 12:50 p.m. ET).

● NXDR → CEO Nirav Tolia fireside chat at Citi Technology Conference (Sept 4, 1:50 p.m. PT, NYC).

● XWEL → Grand opening of new wellness center in Orlando, FL (Sept 5), with participation from Orlando Magic.

● MREO → Licensing agreement with āshibio for vantictumab (ADO2). Supporting data presented at ASBMR 2025 (Sept 5–8, Seattle, WA).

● CURI → Declared Q3 dividend of $0.08/share, payable Sept 19, 2025 (record date: Sept 5, 2025).

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.